Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 2Recruiting 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Obesity 1Endometrial Neoplasms 1

Interventions

pembrolizumab 567Specimen Handling 487Carboplatin 456Magnetic Resonance Spectroscopy 442Cyclophosphamide 418Cisplatin 412Radiotherapy 353Gemcitabine 318Bevacizumab 317Paclitaxel 304Biopsy 291Drug Therapy 286Blood Specimen Collection 249Capecitabine 244Oxaliplatin 242fludarabine 238Nivolumab 236venetoclax 227Injections 214Docetaxel 209Fluorouracil 204Dexamethasone 187Radiosurgery 182Rituximab 162Pemetrexed 160Standard of Care 156Surgical Procedures, Operative 148durvalumab 146atezolizumab 146tislelizumab 140

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Bariatric Surgery × Clear all
NCT04008563 2025-03-14

B-FiERCE

University Health Network, Toronto

Phase NA Recruiting
36 enrolled
Gynecologic

Endometrial Neoplasms

NCT06059651 2025-02-17

The Effects of Metabolic & Bariatric Surgery on Lipid Metabolism, Myeloid-Derived Suppressor Cells, and Cancer Cell Biology

Pennington Biomedical Research Center

Recruiting
20 enrolled
Other

Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡